Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07536841
Recruiting
Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis
Not applicable · Ukraine · 1 site
Registry update: 28 May 2026
NCT07549373
Recruiting
Effect of Diode Laser, Gudmar and Vinegar in Diabetic Patients During Root Canal Treatment
Not applicable · India · 1 site
Registry update: 28 May 2026
NCT07405190
Recruiting
Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
Phase 2 · United States · 3 sites
Registry update: 15 Jul 2026
NCT07591012
Recruiting
Sodium Butyrate and Kluyveromyces Marxianus Supplementation in Inflammatory Bowel Disease
Not applicable · Italy · 1 site
Registry update: 15 May 2026
NCT07627763
Recruiting
Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease
Not applicable · France · 6 sites
Registry update: 4 Jun 2026
NCT07360587
Recruiting
Thyroid Artery Embolization for the Treatment of Compressive Goiters.
Not applicable · Canada · 1 site
Registry update: 3 Nov 2026
NCT07610395
Recruiting
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Phase 2 · United Kingdom, United States · 46 sites
Registry update: 22 Oct 2026
NCT07513714
Recruiting
ESTIM-UL: FES for Upper Limb Recovery After Stroke
Not applicable · Italy · 1 site
Registry update: 22 Sept 2026
NCT07415720
Recruiting
Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.
Not applicable · Spain · 1 site
Registry update: 29 Apr 2026
NCT07403136
Recruiting
Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC
Phase 2 · China · 1 site
Registry update: 7 Jul 2026
NCT07053436
Recruiting
Horizon Two: HR NDMM (MMRC-100)
Phase 2 · United States · 12 sites
Registry update: 2 Oct 2026
NCT07573176
Recruiting
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Phase 3 · Argentina, Brazil, Canada, China, Malaysia, Taiwan, United States · 53 sites
Registry update: 3 Nov 2026
NCT07423533
Recruiting
Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD
Phase 2 · China · 1 site
Registry update: 22 May 2026
NCT07554755
Recruiting
TIS for NSSI in Adolescent Depression
Not applicable · China · 1 site
Registry update: 28 Apr 2026
NCT07603583
Recruiting
Assessment of Heart Rate Variability for Predicting Obstructive Sleep Apnea in Patients With Hypertension
Not applicable · Taiwan · 1 site
Registry update: 22 May 2026
NCT07567482
Recruiting
Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease
Not applicable · Canada · 1 site
Registry update: 13 May 2026
NCT07416058
Recruiting
PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC
Phase 2 · China · 1 site
Registry update: 23 Oct 2026
NCT07545902
Recruiting
Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis
Not applicable · Italy · 1 site
Registry update: 28 Jul 2026
NCT07553338
Recruiting
Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
Phase 2 · United States · 1 site
Registry update: 22 May 2026
NCT07521475
Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Not applicable · United States · 27 sites
Registry update: 3 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.